Science Advisory Team

Dr. Uday Saxena

Dr. Uday Saxena is Co-Founder and Chief Ideator of Reagene Biosciences. He was “Mentor –in-Residence” and Professor of Translational Research at Dr.Reddy’s Institute of Life Sciences as well as Co-Founder of start-up Biotech Company. He has held Executive and Leadership positions at Parke-Davis, AtheroGenics, Dr.Reddy’s Laboratories and Kareus Therapeutics. He is responsible for leading teams that brought several drug candidates from idea into the clinic. He likes to use “disruptive science” to discover and understand new therapies.


Prof P.V.S. Kishore

Prof. P.V.S. Kishore is a prof in the Department of Veterinary Anatomy at NTR College of Veterinary Science and Sri Venkateshwara Veterinary University Tirupati.


Dr. Subrahmanyam Vangala

Dr. Subrahmanyam Vangala  is the founder and CEO of ReaGene Biosciences Private Limited. He is an experienced pharma scientist and executive with more than two decades of leadership experience at global pharma in USA (Wyeth, JNJ., Purdue Pharma and Shire) and Contract Research Organizations in India (Sai Life and Advinus). He brings with him, unique insights into providing cost effective alternative solutions for substituting animal studies for regulatory products. He received his PhD in Biochemistry from Memorial University, Canada and postdoctoral experience at University of Colorado at Boulder and University of California at Berkeley.


Dr. Manjunath Ramarao

Dr. Manjunath Ramarao is the Executive Director, Site Leader, Research and Early Development, BBRC and Head of Discovery Biology and Translational Medicine, BBRC at Bristol-Myers Squibb. He leads a large team of scientists involved in drug discovery research efforts spanning diverse areas including in vitro biology, mechanistic biochemistry, genomics, protein sciences, biophysics, crystallography, electrophysiology, computational biology, compound management and automation. He joined BMS in 2009 after an industrious career at Wyeth, Cambridge, MA, USA, which spanned over eight years where he initiated and successfully led several drug discovery programs. Prior to that he worked as an Instructor in Neurobiology at Harvard Medical School, Boston, MA, USA. He holds Ph.D. and MS in Physiology from the University of Illinois at Urbana-Champaign, USA and MSc (Biochemistry) and B.Sc. from Bangalore University, India.


Dr. Sreedhara Rao Voleti

Dr. Sreedahara Rao Voleti  is currently the Chief Executive Officer at ASPIRE-BioNEST, University of Hyderabad and Founder, Managing Director of INDRAS Pvt. Ltd. Sree comes from research background with more than a decade of pharmaceutical research experience in silico methods, and drug discovery whose synergistic application has huge impact in identifying rationale for mechanism of action of drugs. He is a multifaceted individual with diverse flavors of research expertise in science, engineering, management, entrepreneurship, and leadership. He is a passionate entrepreneur, consultant, startup entertainer, leader and mentor with over 20 years of pharma R & D experience. He was Co-Founder and CSO at Theraxel Discoveries Pvt. Ltd and Head of CADD at Ranbaxy and ILS. He obtianed his Ph.D from IISc Bangalore and Post-Docs from University of Massachusetts and Washington State University, USA.


Dr. Subhadra Dravida

Dr. Subhadra Dravida is the Founder and CEO of Transcell Oncologics Pvt. Ltd. She is an entrepreneurial technocrat of global standing having worked in the USA, Canada and India in the domains of stem cell research/biobanking and product development. She has unique blend of skills of wet lab, product development to managing business. She is a biologist by education with clinical informatics research experience having associated professionally with the University of North Carolina, USA, Ottawa Health Research Institute, Canada.